000 03668nam a22003735i 4500
001 310424
003 MX-SnUAN
005 20160429160404.0
007 cr nn 008mamaa
008 150903s2010 ne | o |||| 0|eng d
020 _a9789048130405
_99789048130405
024 7 _a10.1007/9789048130405
_2doi
035 _avtls000365227
039 9 _a201509031053
_bVLOAD
_c201405070409
_dVLOAD
_y201402211247
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
050 4 _aRC261-271
100 1 _aDittmar, Thomas.
_eeditor.
_9351176
245 1 0 _aStem Cell Biology in Health and Disease /
_cedited by Thomas Dittmar, Kurt S. Zanker.
264 1 _aDordrecht :
_bSpringer Netherlands,
_c2010.
300 _axii, 426 páginas
_brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
500 _aSpringer eBooks
505 0 _aBone marrow-derived stem cells -- Hematopoietic Stem and Progenitor Cells in Clinical Use – Transplantation and Mobilization -- Ex Vivo Expansion of HSPCs -- Modulation of Hematopoietic Stem/Progenitor Cell Migration -- Properties of Mesenchymal Stem Cells to Consider for Cancer Cell Therapy -- Embryonic Stem Cells -- Alternative Embryonic Stem Cell Sources -- Cell Therapy in Parkinson’s Disease -- Transplantation of Stem Cells and Their Derivatives in the Treatment of Multiple Sclerosis -- Cancer Stem Cells -- Cancer: A Stem Cell-based Disease? -- Stem Cell Niche Versus Cancer Stem Cell Niche – Differences and Similarities -- The Chronically Inflamed Microenvironment and Cancer Stem Cells -- Does the Chronically Inflamed Periodontium Harbour Cancer Stem Cells? -- Leukemia Stem Cells -- Cancer Stem Cells in Solid Tumors -- “One for All” or “All for One”? – The Necessity of Cancer Stem Cell Diversity in Metastasis Formation and Cancer Relapse -- Elimination of Cancer Stem Cells -- Potential Molecular Therapeutic Targets in Cancer Stem/Progenitor Cells: Are ATP-Binding Cassette Membrane Transporters Appropriate Targets to Eliminate Cancer-Initiating Cells?.
520 _aStem Cell Biology in Health and Disease presents an up-to-date overview about the dual role of stem cells in health and disease. The Editors have drawn together an international team of experts providing chapters which, in this fully-illustrated volume, discuss: - the controversial debate on the great expectations concerning stem cell based regeneration therapies raised by the pluripotency of various stem cells. - the advantages and concerns about embryonic stem cells (ES cells), induced pluripotent stem cells (iPS cells) and adult stem cells, such as bone marrow-derived stem cells (BMDCs). - the type of stem cells, which has become of interest in the past decade, namely so-called cancer stem cells (CSCs). CSCs are now in the focus of cancer research since the eradication of tumour initiating cells would raise the changes of definitely cure cancer. Professor Dittmar and Professor Zänker have edited a must-read book for researchers and professionals working in the field of regenerative medicine and/or cancer.
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700 1 _aZanker, Kurt S.
_eeditor.
_9351177
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9789048130399
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-90-481-3040-5
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c310424
_d310424